As of Dec 02
| +0.04 / +4.82%|
The 3 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 3.00, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +244.83% increase from the last price of 0.87.
The current consensus among 3 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.